Talimogene Laherparepvec in Combination With Pembrolizumab Leads to a Complete Response in a Patient With Refractory Merkel Cell Carcinoma
JAAD Case Reports - United States
doi 10.1016/j.jdcr.2018.10.003
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2018
Authors
Publisher
Elsevier BV